Results 101 to 110 of about 6,400,597 (307)
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala +15 more
wiley +1 more source
Modelling of Housing Construction in Accordance with Climatic Factors of Chabahar [PDF]
mohamad saleigeh
doaj +1 more source
In contrast to what literary representations would have us believe, the house appears to be the most common place for rape in the court records from late medieval cities.
Maëliss Nouvel
doaj +1 more source
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang +3 more
wiley +1 more source
Enduring Advantage of Settlement Houses [PDF]
Examines the distinctive practice the settlement house model has generated and illustrates how this practice creates a settlement house advantage that is worthy of attention.
core
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee +8 more
wiley +1 more source
GRIYA DAN OMAH Penelusuran Makna dan Signifikasi di Arsitektur Jawa
Terms and names in architecture may sometimes be powerful in exploring history of ideas. Philology and hermeneutics are discipline of knowledge that utilize this notion in a very throgh and critical way.
Josef Prijotomo
doaj
“Housing Without Housing” en Marruecos [PDF]
Universidad de ...
openaire +2 more sources
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat +8 more
wiley +1 more source

